Structural requirements for substrates and inhibitors of angiotensin I-converting enzyme in vivo and vitro.
D000596:Amino Acids / Q000032:analysis; D000626:Aminopeptidases / Q000378:metabolism; D000804:Angiotensin II / Q000097:blood / Q000378:metabolism*; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001322:Autoanalysis; D001681:Biological Assay; D002852:Chromatography, Ion Exchange; D002918:Chymotrypsin / Q000378:metabolism; D004285:Dogs; D004590:Electrophoresis, Paper; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D006868:Hydrolysis; D066298:In Vitro Techniques; D007457:Iodine Radioisotopes; D008722:Methods; D011652:Pulmonary Circulation; D014357:Trypsin / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism
D000596:Amino Acids; D000806:Angiotensin-Converting Enzyme Inhibitors; D007457:Iodine Radioisotopes; D000804:Angiotensin II; D014443:Tyrosine; D006493:Heparin; D000626:Aminopeptidases; D002918:Chymotrypsin; D014357:Trypsin